ZIF-8-Based Surface Plasmon Resonance and Fabry-Pérot Sensors for Volatile Organic Compounds.

This work explores the use of ZIF-8, a metal-organic framework (MOF) material, for its use in the optical detection of volatile organic compounds (VOCs) in Fabry-Pérot and surface plasmon resonance (SPR)-based sensors. The experiments have been carried out with ethanol (EtOH) and show response times as low as 30 s under VOC-saturated atmospheres, and the estimated limit of detection is below 4000 ppm for both sensor types. The selectivity towards other VOCs is relatively poor, although the dynamics of adsorption/desorption differ for each VOC and could be used for selectivity purposes. Furthermore, the hydrophobicity of ZIF-8 has been confirmed and the fabricated sensors are insensitive to this compound, which is a very attractive result for its practical use in gas sensing devices.

Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review.

Endometrial cancer, the most prevalent gynecological malignancy in developed countries, is experiencing a sustained rise in both its incidence and mortality rates, primarily attributed to extended life expectancy and lifestyle factors. Currently, the absence of precise diagnostic tools hampers the effective management of the expanding population of women at risk of developing this disease. Furthermore, patients diagnosed with endometrial cancer require precise risk stratification to align with optimal treatment planning. Metabolomics technology offers a unique insight into the molecular landscape of endometrial cancer, providing a promising approach to address these unmet needs. This comprehensive literature review initiates with an overview of metabolomic technologies and their intrinsic workflow components, aiming to establish a fundamental understanding for the readers. Subsequently, a detailed exploration of the existing body of research is undertaken with the objective of identifying metabolite biomarkers capable of enhancing current strategies for endometrial cancer diagnosis, prognosis, and recurrence monitoring. Metabolomics holds vast potential to revolutionize the management of endometrial cancer by providing accuracy and valuable insights into crucial aspects.